IPO Search Results for Vallon Pharmaceuticals

Company	Ticker	Business Description	Underwriters	Offer Date
GRI Bio	GRI	Developing abuse-deterrent prescription drugs for CNS disorders.	ThinkEquity	02/09/21

Showing 1 to 1 of 1 entries